Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
March 20 2024 - 8:15AM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, today announced it will report fourth quarter and full
year 2023 financial results before the market opens on Friday,
March 22, 2024. Following the release, the Company will host a live
conference call and webcast at 8:30 a.m. ET to discuss
the Company’s financial results and provide a business update.
Event |
Agile Therapeutics Fourth
Quarter & Full Year 2023 Financial Results Conference Call |
Date |
Friday, March 22, 2024 |
Time |
8:30 a.m. ET / 5:30 a.m.
PT |
|
|
A live webcast of the conference call may be accessed via the
Investor Relations portion of the Agile Therapeutics website
at https://ir.agiletherapeutics.com/events-and-presentations.
To participate in the live conference call via telephone, please
register here. Upon registering, a dial-in number and unique
PIN will be provided to join the conference call.
About Agile
Therapeutics, Inc.
Agile Therapeutics is a women's healthcare
company dedicated to fulfilling the unmet health needs of today’s
women. Our product and product candidates are designed to provide
women with contraceptive options that offer freedom from taking a
daily pill, without committing to a longer-acting method. Our
initial product, Twirla®, (levonorgestrel and ethinyl estradiol)
transdermal system, is a non-daily prescription contraceptive.
Twirla is based on our proprietary transdermal patch technology,
called Skinfusion®, which is designed to allow drug delivery
through the skin. For more information, please visit the company
website at www.agiletherapeutics.com. The Company
may occasionally disseminate material, nonpublic information on the
Company’s website and LinkedIn account.
Contact:
Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2024 to May 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From May 2023 to May 2024